5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
本周有关生物技术的5支股票的重要催化剂：默沙东、Intellia、Verona等等。
Biotech stocks are high-risk, high-return opportunities that are under the mercy of several make-or-break catalysts, most of which are binary events. It pays to remain cognizant of the timing of these catalysts and which way they will likely pan out.
生物科技股是高风险、高回报的机会，受多种成败催化剂的摆布，其中大多数是二元事件。了解这些催化剂的时机以及它们可能以何种方式发挥作用是值得的。
Benzinga brings to investors a weekly feature focusing on five key catalysts that could impact the stock prices of the respective companies in an appreciable manner.
Benzinga每周为投资者带来专题报道，重点关注五种关键催化剂，这些催化剂可能会对各自公司的股价产生明显影响。
1. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
1。Arrowhead Pharmicals, Inc.（纳斯达克股票代码：ARWR）
Date: Tuesday, June 25
Catalyst: Discussion of Phase 3 PALISADE study of investigational plozasiran in patients with genetically confirmed or clinically diagnosed familial chylomicronemia syndrome
日期：6月25日星期二
催化剂：讨论针对经基因确认或临床诊断的家族性乳糜微粒血症综合征患者的在研plozasiran的3期PALISADE研究
On June...
6月...
登录免费看全文
登录/注册